liver cirrhosis
Conditions
Interventions
Remazolam group ( Group R):Intravenous injection of remazolam besylate
Propofol group (Group P):Intravenous injection of propofol
Sponsors
Beijing Ditan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-65 years old, regardless of gender. Patients with Child-Pugh below grade A or B,undergoing gastroscopy. American Society of Anesthesiologists ASA Class II-III. BMI 18.5-30kg/m2. Patients who are told to volunteer for the trial and signed informed consent forms. Expected survival > 6 months.
Exclusion criteria
Exclusion criteria: Patients who explicitly refuse to participate in the study. Patients with a history of serious heart, brain, lung, kidney and metabolic diseases. Patients with a history of recovery from abnormal surgical anesthesia. Electrocardiogram: heart rate 180mmHg and/or diastolic blood pressure >110mmHg in hypertensive patients, or <90/60mmHg in hypotensive patients. Patients with neuromuscular system diseases or mental diseases. Patients suspected abuse of narcotic analgesics or sedatives. Patients that the researcher considers inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of hypotension; | — |
Secondary
| Measure | Time frame |
|---|---|
| Low oxygen saturation, airway obstruction, respiratory depression, apnea, bradycardia, tachycardia and other adverse reactions;Satisfaction rating;Postoperative adverse reactions;Frequency and dose of vasoactive drugs; | — |
Countries
China
Contacts
Public ContactZhao jinying
Beijing Ditan Hospital, Capital Medical University
Outcome results
None listed